Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Carrie
Carrie Buergener, Mountainview, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100145976 | SYSTEM AND METHOD FOR CONTEXT BASED QUERY AUGMENTATION - A system and method for context based query augmentation. A question is received over a network from a questioning user comprising an identification of a user and at least one question criteria. A first query is formulated so as to search, via the network, for user profile data, social network data, spatial data, temporal data and topical data so as to identify user context data relevant to question criteria. The question is modified using the user context data to create at least one modified question having at least one additional criteria based on the user context data. A second query is formulated so as to search, via the network, for knowledge data, user profile data, social network data, spatial data, temporal data and topical data so as to identify knowledge data relevant to the identified user and the modified question criteria. The knowledge data is transmitted, over the network, to the questioning user. | 06-10-2010 |
Carrie Carlander, Pollar, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120102147 | CONTROLLING, FILTERING, AND MONITORING OF MOBILE DEVICE ACCESS TO THE INTERNET, DATA, VOICE, AND APPLICATIONS - Systems and methods for controlling, filtering, and monitoring mobile device access to the internet are disclosed. According to an embodiment a server is responsible for controlling, filtering and monitoring internet activity. For every request, the server interacts with back-end databases that categorize requests, and based on user/carrier/corporate settings, allow or disallow access to particular content. | 04-26-2012 |
| 20120102544 | CONTROLLING, FILTERING, AND MONITORING OF MOBILE DEVICE ACCESS TO THE INTERNET, DATA, VOICE, AND APPLICATIONS - Systems and methods for controlling, filtering, and monitoring mobile device access to the internet are disclosed. According to an embodiment a server is responsible for controlling, filtering and monitoring internet activity. For every request, the server interacts with back-end databases that categorize requests, and based on user/carrier/corporate settings, allow or disallow access to particular content. | 04-26-2012 |
Carrie Carlander, Poway, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120071132 | CONTROLLING, FILTERING, AND MONITORING OF MOBILE DEVICE ACCESS TO THE INTERNET, DATA, VOICE, AND APPLICATIONS - Systems and methods for controlling, filtering, and monitoring mobile device access to the internet are disclosed. According to an embodiment a server is responsible for controlling, filtering and monitoring internet activity. For every request, the server interacts with back-end databases that categorize requests, and based on user/carrier/corporate settings, allow or disallow access to particular content. | 03-22-2012 |
Carrie Chitsey, Cedar Park, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20100323729 | ELECTRONIC CARD PRESENTATION AND EXCHANGE - An information distribution and management system is disclosed. The information distribution and management system includes method and system for presenting and distributing electronic business cards. Once a user is registered, provides contact information to a database, and designates which of the contact information to include in the user's contact profile, the user can instruct the system to send an email to a third party upon request. Alternatively, a third party can request and receive the user's contact profile upon request. In certain embodiments, a keyword may be used to restrict access to the user's contact profile. | 12-23-2010 |
Carrie Haskell-Luevano, Archer, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20080207518 | Adrenocorticotropic Hormone Analogs and Related Methods - ACTH analog compounds of the present invention include compounds comprising an ACTH peptide sequence with one or more structural modifications that can have one or more of the following preferred ACTH analog biological functions: (1) reduction of corticosteroid secretion by adrenal membrane in the presence of the ACTH analog compared to unmodified ACTH, (2) reduction of corticosteroid secretion by adrenal membrane in the presence of endogenous ACTH and (3) increased MC-2R binding affinity with reduced activation of the MC-2R receptor compared to unmodified ACTH binding to the MC-2R melanocortin. The ACTH analog compounds of the present invention are therefore useful for treatment or prevention of diseases and disorders related to ACTH, ACTH receptors or corticosteroid secretion, such as premature labor and Cushing's Disease. | 08-28-2008 |
| 20090176712 | Peptides with Efficacy in Rescuing Melanocortin-4 Receptor Polymorphic Agonist Signaling - Disclosed are novel ligands based on an AGRP template that can rescue endogenous melanocortin agonist and/or antagonist dysfunction at MCR polymorphisms. In particular, the present invention provides novel synthetic ligands based on AGRP templates that can rescue endogenous melanocortin agonist dysfunction at MC4R polymorphisms to treat children and adults with these mutations and increase their quality of life. | 07-09-2009 |
| 20100260681 | ADRENOCORTICOTROPIC HORMONE ANALOGS AND RELATED METHODS - ACTH analog compounds of the present invention include compounds comprising an ACTH peptide sequence with one or more structural modifications that can have one or more of the following preferred ACTH analog biological functions: (1) reduction of corticosteroid secretion by adrenal membrane in the presence of the ACTH analog compared to unmodified ACTH, (2) reduction of corticosteroid secretion by adrenal membrane in the presence of endogenous ACTH and (3) increased MC-2R binding affinity with reduced activation of the MC-2R receptor compared to unmodified ACTH binding to the MC-2R melanocortin. The ACTH analog compounds of the present invention are therefore useful for treatment or prevention of diseases and disorders related to ACTH, ACTH receptors or corticosteroid secretion, such as premature labor and Cushing's Disease. | 10-14-2010 |
Carrie Kraling, Brooklyn Park, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20110200681 | Abuse Resistant Drug Formulation - A pharmaceutical composition may include a granulate which may include at least one active pharmaceutical ingredient susceptible to abuse by an individual mixed with at least two materials, a first material that is substantially water insoluble and at least partially alcohol soluble and a second material that is substantially alcohol insoluble and at least partially water soluble, wherein the active pharmaceutical ingredient and the two materials are granulated in the presence of water and alcohol. The composition may also include a coating on the granulate exhibiting crush resistance which may have a material that is deposited on the granulate using an alcohol based solvent. The composition further comprises a second particle comprising a fat/wax. The present invention also includes a coated granulate, various dosage forms of the composition, as well as methods of production and tableting. | 08-18-2011 |
Carrie Pateras, Boardman, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20090036856 | TRIGGERABLE SELF-GENERATING LIQUID FOAM BARRIER/INTERCEPTOR - The present disclosure generally relates to absorbent articles, such as diapers, training pants, swim pants, incontinence articles, feminine care articles, and the like, that comprise a system for generating a fluid or odor barrier or interceptor. More specifically, the articles comprise a pre-use foam composition that when contacted with a triggering agent, expands to produce a foam barrier or interceptor structure that provides protection against leakage of the absorbent article. | 02-05-2009 |
Carrie Shawber, Township Of Washington, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100273990 | Notch-based fusion proteins and uses thereof - This invention provides a method for treating a subject having a tumor and a method for inhibiting angiogenesis in a subject, both comprising administering to the subject an effective amount of a composition of matter comprising the extracellular domain of a Notch receptor protein operably affixed to a half-life-increasing moiety. This invention also provides a composition of matter comprising the extracellular domain of Notch4 receptor protein operably affixed to a half-life-increasing moiety. This invention further provides an article of manufacture. Finally, this invention provides a replicable vector which encodes a polypeptide comprising the extracellular domain of a Notch receptor protein operably affixed to a half-life-increasing moiety, a host vector system which comprises such replicable vector and a method of producing such polypeptide. | 10-28-2010 |
| 20110008342 | COMPOSITIONS OF HUMANIZED NOTCH FUSION PROTEINS AND METHODS OF TREATMENT - This invention provides a fusion protein comprising a single peptide, an extracellular domain of human Notch receptor protein and an Fc portion of an antibody bound thereto. This invention also provides a method for treating a subject having a tumor, a method for inhibiting angiogenesis in a subject, a method for treating a subject having ovarian cancer, and a method for treating a subject having a metabolic disorder, comprising administering to the subject an amount of the above fusion protein effective to treat the subject. This invention further provides uses of the above fusion protein for the preparation of a pharmaceutical composition for the treatment of a subject having a tumor, for inhibiting angiogenesis in a subject, for treating a subject having ovarian cancer, and for treating a subject having a metabolic disorder. | 01-13-2011 |
Carrie Shawber, Washington Township, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110223183 | HUMAN NOTCH3 BASED FUSION PROTEINS AS DECOY INHIBITORS OF NOTCH3 SIGNALING - This invention provides a fusion protein comprising a signal peptide, EGF repeats 1-X of the extracellular domain of human Notch3 receptor protein wherein X is any integer from 12 to 34, and an Fc portion of an antibody bound thereto. This invention also provides a method for treating a subject having a tumor, a method for inhibiting angiogenesis in a subject, a method for treating a subject having ovarian cancer, and a method for treating a subject having a metabolic disorder, comprising administering to the subject an amount of the above fusion protein effective to treat the subject. This invention further provides uses of the above fusion protein for the preparation of a pharmaceutical composition for the treatment of a subject having a tumor, for inhibiting angiogenesis in a subject, for treating a subject having ovarian cancer, and for treating a subject having a metabolic disorder. | 09-15-2011 |
Carrie Sona, St. Louis, MO US
| Patent application number | Description | Published |
|---|---|---|
| 20100312076 | POP BOX METHODS AND SYSTEMS FOR ASSESSING RISK OF PRESSURE RELATED SKIN INJURY AND DETERMINING A RECOMMENDED TREATMENT THEREOF - A system or method for assessing a patient for pressure related skin injury risk and recommended treatment including measuring extrinsic and intrinsic skin pressure of the patient and assigning a rating responsive to the skin pressure measurement, measuring oxygenation of the patient and assigning a rating responsive to the oxygenation measurement, measuring perfusion of the patient and assigning a rating responsive to the perfusion measurement, summing the skin pressure, oxygenation and perfusion ratings to obtain a POP Box score, determining a risk of pressure related skin injury for the patient in response to the POP Box score, and determining or selecting a recommended treatment from among a plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury. | 12-09-2010 |
Carrie Sun, Tucker, GA US
| Patent application number | Description | Published |
|---|---|---|
| 20080280294 | Inherited Mitochondrial Dna Mutations in Cancer - A method is provided for identifying a subject likely to have, or at risk of developing a disease condition correlated with increased reactive oxygen species (ROS), including cancer, by identifying in the subject a missense mutation in a nucleic acid of Complex III, IV and/or V of the OXPHOS system. This invention also provides a method of identifying a likelihood of having a heritable predisposition to cancer by detecting a homoplasmic missense mutation in non-tumor tissue of an OXPHOS system gene. This invention also provides a method for detecting likelihood of having cancer, predisposition to cancer, and likelihood of passing a predisposition to cancer to progeny involving identifying in non-tumor tissue of the subject a missense mutation in a complex III, IV and/or V gene of the mitochondrial OXPHOS system. The mutation may be a nuclear or mitochondrial mutation. The invention has been exemplified with respect to prostate cancer. When the mutation is homoplasmic in non-tumor tissue this is an indication it is an inherited and inheritable trait, and that the subject is likely to pass on the mutation to her progeny in the case of mutations in mitochondrial DNA or his or her progeny in the case of mutations in nuclear DNA. Both homoplasmic and heteroplasmic mutations in non-tumor tissue can indicate the presence of cancer. | 11-13-2008 |
Carrie Vriheas, San Francisco, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080257966 | PACKAGING FOR A PORTABLE CONSUMER DEVICE - A portable consumer device having an information bearing region is packaged with an anti-tampering member. The region includes information pertaining to an account associated with a payment processing system. With a permanent alteration of the anti-tampering member so as to make the region accessible, a merchant's point of service terminal can interact with the region so as to change a state of the account. | 10-23-2008 |
| 20090084842 | AUTOMATED SUBMISSION OF PREPAID PROGRAMS - A payment system includes transaction handler that processes transactions, each characterized by a consumer and a merchant engaging in a sales transaction involving a prepaid program having prepaid cards, such as a gift card, that an issuer provides to consumers. A method for establishing a prepaid program includes the issuer remotely accessing a computer system at the transaction handler. The computer system presenting the issuer with a program information form on which the issuer enters requested data. As each data item is entered, the computer system checks for errors, which are identified to and corrected by the issuer in real time. The issuer submits the data as a request to create a prepaid program, which the transaction handler reviews and responds by approving or rejecting creation of the prepaid program. The transaction handler electronically communicates approval or rejection of the prepaid program to the issuer. | 04-02-2009 |